Literature DB >> 7598480

The changing face of tuberculosis.

R E Huebner1, K G Castro.   

Abstract

Tuberculosis (TB) remains an important public health problem worldwide, resulting in a estimated 8 to 10 million new cases and 2 to 3 million deaths each year. Between 1953 and 1985, the number of TB cases in the US declined by an average of 6% per year. However, since 1985, TB has been increasing in the US. Approximately 64,000 additional cases of the disease have been reported beyond the number expected had the rate of decline observed from 1980 to 1984 continued from 1985 through 1993. Increases in the number of TB cases have been significant in racial and ethnic minorities, in persons born outside the US, and in children less than 15 years of age. Infection with the human immunodeficiency virus (HIV) has also been recognized as a major risk factor for the development of active TB in persons with latent Mycobacterium tuberculosis infection. The unusual radiographic findings and the increased likelihood of extrapulmonary TB in HIV-infected persons make diagnosis of the disease problematic. Lastly, concomitant with the resurgence of TB has been the emergence of drug resistance. All of these factors make successful control of TB in the US difficult.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598480     DOI: 10.1146/annurev.med.46.1.47

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  10 in total

1.  Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City.

Authors:  R C Cooksey; G P Morlock; A McQueen; S E Glickman; J T Crawford
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 2.  Impact of HIV infection on tuberculosis.

Authors:  A Zumla; P Malon; J Henderson; J M Grange
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

3.  Establishment of a neonatal rhesus macaque model to study Mycobacterium tuberculosis infection.

Authors:  Magdalena Cepeda; Mary Salas; Jessica Folwarczny; Ana C Leandro; Vida L Hodara; Melissa A de la Garza; Edward J Dick; Michael Owston; Lisa Y Armitige; Marie-Claire Gauduin
Journal:  Tuberculosis (Edinb)       Date:  2013-12       Impact factor: 3.131

Review 4.  Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection.

Authors:  Asha Anandaiah; Keertan Dheda; Joseph Keane; Henry Koziel; David A J Moore; Naimish R Patel
Journal:  Am J Respir Crit Care Med       Date:  2010-12-22       Impact factor: 21.405

5.  Identification of an Immunomodulating Agent from Mycobacterium leprae.

Authors:  Yumi Maeda; Tetsu Mukai; John Spencer; Masahiko Makino
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitis.

Authors:  Gokul Raj Kathamuthu; Nathella Pavan Kumar; Kadar Moideen; Dhanaraj Baskaran; Syed Hissar; Basavegowdanadoddi M Shrinivasa; Rathinam Sridhar; Subash Babu
Journal:  Cytokine       Date:  2018-06-02       Impact factor: 3.861

Review 7.  Combating Tuberculosis Infection: A Forbidding Challenge.

Authors:  Tejal Rawal; Shital Butani
Journal:  Indian J Pharm Sci       Date:  2016 Jan-Feb       Impact factor: 0.975

8.  Novel Thiazolidinone-Azole Hybrids: Design, Synthesis and Antimycobacterial Activity Studies.

Authors:  Barbaros Eroglu; Keriman Ozadali-Sari; Oya Unsal-Tan; Sriram Dharmarajan; Perumal Yogeeswari; Ayla Balkan
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

9.  Extrapulmonary tuberculosis by nationality, The Netherlands, 1993-2001.

Authors:  Lowieke A M te Beek; Marieke J van der Werf; Clemens Richter; Martien W Borgdorff
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

10.  Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification.

Authors:  D J Hackam; O D Rotstein; W Zhang; S Gruenheid; P Gros; S Grinstein
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.